Advertisement

Prognostic significance of serum γ-glutamyltransferase in advanced urothelial carcinoma patients

Login to Access Video or Poster Abstract: MP34-17
Sources of Funding: None

Introduction

γ-glutamyltransferase (GGT), which is expressed in various human cancer cells, is known as a membrane-bound enzyme playing a protective role from oxidative stress. Recent studies indicated that GGT can also exert pro-oxidant effects at the membrane surface and the extracellular microenvironment, contributing to the regulation of proliferative/apoptotic balance, the acquisition of chemo-resistance, and cancer progression. Here, we explored the prognostic role of serum GGT in advanced urothelial carcinoma (aUC) patients.

Methods

This retrospective study included 126 consecutive aUC patients (inoperable cT4 and/or metastases to lymph nodes/distant organs) treated at a single cancer center from 2004 to 2016. Of the 126 patients, 93 (74%) received systemic chemotherapy. Variables collected included age, gender, performance status (PS), body mass index (BMI), hydronephrosis, primary site, lymph node/visceral metastasis, prior curative surgery, therapies for aUC, hemoglobin, white blood cell count, creatinine, albumin, alkaline phosphatase, lactate dehydrogenase (LDH), corrected calcium, C-reactive protein (CRP), aspartate/alanine aminotransferase, and GGT. We assessed variables associated with overall survival (OS) using the Cox proportional hazards model.

Results

The median (range) serum GGT was 26 (7-252) U/L. During follow-up (median 12M), 92 patients died (2Y OS rate 24%). On multivariate analysis, GGT was an independent predictor for OS (HR 1.01 as a continuous variable, p = 0.007) along with age (HR 1.04, p = 0.003), BMI (HR 0.92, p = 0.005), visceral metastasis (HR 1.92, p = 0.006), albumin (HR 0.49, p = 0.032), log LDH (HR 2.63, p < 0.001), and log CRP (HR 1.41, p < 0.001). Next, the optimal cut-off of GGT was determined. When patients with GGT ≥43 U/L were defined as elevated, HR was highest on univariate Cox proportional hazards analysis (2.16). The 2Y OS rates for patients with elevated and non-elevated GGT were 5% and 30%, respectively (p < 0.001). The prognostic significance of elevated GGT was confirmed in multivariate analysis (HR 2.29, p = 0.001). Incorporation of GGT into the Bajorin&[prime]s model (PS and visceral metastasis) improved the c-index from 0.654 to 0.685.

Conclusions

This study is the first to demonstrate the prognostic significance of serum GGT in aUC patients.

Funding

None

Authors
Hiroshi Fukushima
Yasukazu Nakanishi
Madoka Kataoka
Ken-ichi Tobisu
Fumitaka Koga
back to top